Fig. 1From: Utilizing biologic disease-modifying anti-rheumatic treatment sequences to subphenotype rheumatoid arthritisMedication sequences for a random 30 RA subjects from each cluster with ≥ 15 sequences. Only the first 15 sequences (3.75 years of medication data) are shown, even if the subject had additional bDMARD prescriptionsBack to article page